Plandemic II Launched to Keep Pandemic Funds Flowing to Big Pharma: MonkeyPox

Plandemic II Launched to Keep Pandemic Funds Flowing to Big Pharma: MonkeyPox by Brian Shilhavy, Editor, Health Impact News

After weeks of indicating that perhaps the Bird Flu hoax was going to be recycled again as a new “pandemic” to instill fear and continue the state of “emergency” the entire country has been under since 2020 that has resulted in $trillions given over to Big Pharma for their products, mainly the COVID-19 “vaccines,” it appears now that plans are in place to actually use the “monkeypox” as the new “pandemic” to further the goals of the Globalists to create new vaccines and control the population.

The World Health Organization just announced that they are “convening an emergency meeting on the alarming spread of monkeypox around the world.” (Source.)

Just how bad is this new “outbreak” which now threatens the world in a similar way to how COVID threatened to wipe out humanity?

Cases of monkeypox in the UK doubled this week – to an “alarming” 20 cases. And it is now spreading to the U.S. at an alarming rate, as one person has reportedly now tested positive for it (determined by the PCR test apparently) in New York City. (Source.)

It appears that worldwide this “alarming spread” of monkeypox is well below 100 cases at this point, which means it would probably not even break into the top 1000 list of current infectious diseases spreading around the globe.

So why the media hype and sudden attention by government health organizations like the WHO and the CDC?

The first clue that this is a new “plandemic” is to see how Big Pharma is setup to profit from it, because disease management is first and foremost a marketing opportunity, and to create to the proper fear factor, one has to advertise a “new” and “deadly” disease to start the funds flowing through emergency use authorizations.

And sure enough, that first criterion for identifying a “plandemic” has been met this week, as Whitney Webb reported:

Two corrupt companies were in rocky financial territory just a few weeks ago. Now, with concerns over a global monkeypox outbreak being hyped by media and global health organizations alike, the worries – and sins – of these two firms are quickly being forgotten.

In recent days, concern over a global outbreak of monkeypox, a mild disease related to smallpox and chickenpox, has been hyped in the media and health ministries around the world, even prompting an emergency meeting at the World Health Organization (WHO). For some, fears have centered around monkeypox being the potential “next pandemic” after Covid-19. For others, the fear is that monkeypox will be used as the latest excuse to further advance draconian biosecurity policies and global power grabs.

Regardless of how the monkeypox situation plays out, two companies are already cashing in. As concern over monkeypox has risen, so too have the shares of Emergent Biosolutions and SIGA Technologies. Both companies essentially have monopolies in the US market, and other markets as well, on smallpox vaccines and treatments. Their main smallpox-focused products are, conveniently, also used to protect against or treat monkeypox as well. As a result, the shares of Emergent Biosolutions climbed 12% on Thursday, while those of SIGA soared 17.1%.

For these companies, the monkeypox fears are a godsend, specifically for SIGA, which produces a smallpox treatment, known by its brand name TPOXX. It is SIGA’s only product. While some outlets have noted that the rise in the valuation of SIGA Technologies has coincided with recent concerns about monkeypox, essentially no attention has been given to the fact that the company is apparently the only piece of a powerful billionaire’s empire that isn’t currently crumbling.

That billionaire, “corporate raider” Ron Perelman, has deep and controversial ties to the Clinton family and the Democratic party as well as troubling ties to Jeffery Epstein. Aside from his controlling stake in SIGA, Perelman has recently made headlines for rapidly liquidating many of his assets in a desperate bid for cash. (Full article.)

Despite the fact that they are hyping this monkeypox

Continue Reading / Health Impact News >>>

Related posts